Related Experiment Video
Updated: Feb 12, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
A novel tetrahydroisoquinoline (THIQ) analogue induces mitochondria-dependent apoptosis
Xia Sun1, Min Liu2, Luyao Gao1
1Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China.
Abstract:
Lung cancer continues to be a leading cause of cancer-related death worldwide, with non-small cell lung cancer (NSCLC) accounting for more than 80% of lung cancer cases. Current therapies for NSCLC have only limited effect and treatment resistance develops rapidly. In a previous study, we have shown that C1-phenylethynyl tetrahydroisoquinoline (THIQ) analogue 4 has anti-proliferative activity against PC3 human prostate cancer cells. However, this anticancer effect was achieved with relatively high IC50 in A549 lung cancer cells. To improve the potency of the drug, in the present study, a series of novel THIQ analogues (analogues 5a-d) were prepared by using an oxidative C-H functionalization strategy, and their potential anticancer activities on A549 lung cancer cells were investigated. Among these analogues, analogue 5c can markedly inhibit A549 cell proliferation in a dose-dependent manner with a reasonable IC50 of 14.61 ± 1.03 μM. This effect was mediated by analogue 5c-induced G0/G1 phase arrest and cell apoptosis. Treatment with analogue 5c was shown to induce reactive oxygen species (ROS) accumulation, disruption of mitochondrial membrane potential, reduction of glutathione, elevation of intracellular calcium ion (Ca2+), and activation of Caspase-3. Furthermore, analogue 5c can lead to DNA double-strand break and the activation of p53 pathway in A549 cells. In conclusion, the oxidative C-H functionalization strategy to generate analogue 5c could improve the drug anticancer efficacy by inducing mitochondria-dependent apoptosis in A549 cells.
Insights
Novel tetrahydroisoquinoline (THIQ) analogues were synthesized to combat non-small cell lung cancer (NSCLC). Analogue 5c effectively inhibited A549 lung cancer cell proliferation by inducing apoptosis and activating key cellular pathways.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Pharmacology
Background:
- Non-small cell lung cancer (NSCLC) remains a major global health concern with limited therapeutic options.
- Existing treatments for NSCLC often face challenges with efficacy and rapid development of drug resistance.
- Previous research indicated anti-proliferative activity of a C1-phenylethynyl tetrahydroisoquinoline (THIQ) analogue in prostate cancer cells, but with lower potency against lung cancer cells.
Purpose of the Study:
- To develop novel THIQ analogues with improved anti-cancer potency against A549 lung cancer cells.
- To investigate the anti-proliferative effects and underlying mechanisms of these new analogues.
- To explore the utility of oxidative C-H functionalization in enhancing drug efficacy.
Main Methods:
- Synthesis of novel THIQ analogues (5a-d) utilizing an oxidative C-H functionalization strategy.
- Evaluation of anti-cancer activity against A549 lung cancer cells, including IC50 determination.
- Assessment of cell cycle progression (G0/G1 arrest) and apoptosis induction.
- Analysis of cellular events such as reactive oxygen species (ROS) generation, mitochondrial membrane potential, glutathione levels, intracellular calcium, and Caspase-3 activation.
- Investigation of DNA damage and p53 pathway activation.
Main Results:
- Analogue 5c demonstrated significant dose-dependent inhibition of A549 cell proliferation with an IC50 of 14.61 ± 1.03 μM.
- Analogue 5c induced cell cycle arrest at the G0/G1 phase and promoted apoptosis.
- Treatment with analogue 5c led to increased ROS, disrupted mitochondrial membrane potential, reduced glutathione, elevated intracellular calcium, and activated Caspase-3.
- Analogue 5c caused DNA double-strand breaks and activated the p53 pathway in A549 cells.
Conclusions:
- The oxidative C-H functionalization strategy successfully generated analogue 5c with enhanced anti-cancer efficacy.
- Analogue 5c exerts its anti-cancer effect by inducing mitochondria-dependent apoptosis in A549 lung cancer cells.
- The findings suggest that analogue 5c is a promising candidate for further development as an NSCLC therapeutic agent.
Related Concept Videos
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
Apoptosis
Mitochondria
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Frequency-dependent Selection
Drug Dependence

